[Research Advances in Targeting the YAP/TAZ Signaling Pathway
to Improve Cancer Immunotherapy].
Pingxu Zhang,
No information about this author
Yiyi Zhan
No information about this author
PubMed,
Journal Year:
2025,
Volume and Issue:
28(3), P. 221 - 229
Published: March 20, 2025
Despite
the
groundbreaking
advances
in
cancer
immunotherapy
achieved
by
immune
checkpoint
inhibitors
(ICIs),
their
efficacy
remains
limited
immunosuppressive
tumor
microenvironment
(TME).
Yes-associated
protein
(YAP)
and
transcriptional
coactivator
with
PDZ-binding
motif
(TAZ),
key
effectors
of
Hippo
signaling
pathway,
play
pivotal
roles
evasion.
They
directly
regulate
expression
checkpoints,
mediate
formation
an
microenvironment,
inhibit
T
cell
function,
interact
other
pathways
to
promote
escape.
Diverse
strategies
targeting
YAP/TAZ
have
been
developed,
including
direct
inhibition,
modulation
upstream
regulators,
suppression
downstream
target
genes.
Preclinical
studies
demonstrated
that
combining
inhibition
ICIs
significantly
enhances
therapeutic
across
various
models.
This
review
summarizes
recent
understanding
role
evasion
within
TME
explores
potential
this
pathway
improve
outcomes.
Furthermore,
it
discusses
translational
value
combination
therapies
based
on
providing
a
theoretical
framework
practical
guidance
for
development
innovative
immunotherapeutic
precision
medicine
approaches.
.
Language: Английский
From Quiescence to Activation: The Reciprocal Regulation of Ras and Rho Signaling in Hepatic Stellate Cells
Cells,
Journal Year:
2025,
Volume and Issue:
14(9), P. 674 - 674
Published: May 5, 2025
Chronic
liver
diseases
are
marked
by
persistent
inflammation
and
can
evolve
into
fibrosis,
cirrhosis,
hepatocellular
carcinoma.
In
an
affected
liver,
hepatic
stellate
cells
(HSCs)
transition
from
a
quiescent
to
activated
state
adopt
myofibroblast-like
cell
phenotype.
While
these
play
role
in
supporting
regeneration,
they
also
have
detrimental
effects
on
function
as
the
disease
progresses
fibrosis
cirrhosis.
These
findings
highlight
dynamic
switching
between
different
signaling
pathways
involving
Ras,
Rho
GTPases,
Notch
signaling.
Notably,
two
specific
members
of
Ras
Eras
Rnd3,
predominantly
expressed
HSCs,
while
Mras
Rhoc
more
abundant
their
forms.
addition,
this
study
highlights
critical
cytosolic
Notch1
HSCs
Rock
HSCs.
We
hypothesize
that
distinct
yet
interdependent
intracellular
networks
regulate
HSC
fate
decisions
key
ways:
maintaining
quiescence
homeostasis
facilitating
activation,
thereby
influencing
processes
such
proliferation,
transdifferentiation,
mesenchymal
transition.
The
proposed
model,
combined
with
methodological
tools
for
state,
will
deepen
our
understanding
mechanisms
underlying
chronic
may
pave
way
innovative
therapies.
therapies
could
include
small
molecule
drugs
targeting
Ras-
Rho-dependent
pathways.
Language: Английский